跳至主要内容
临床试验/NCT06379152
NCT06379152招募中不适用

Effect of Bilirubin on Prognosis in Heart Failure With Preserved Ejection Fraction

Chongqing Medical University1 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2020年9月20日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
400
试验地点
1
主要终点
The level of direct bilirubin

研究概览

简要总结

Factors influencing the prognosis of patients with heart failure with preserved ejection fraction (HFpEF) have been extensively studied. Previous studies have found that elevated serum total bilirubin levels are associated with cardiac death, heart failure readmission, and all-cause mortality in patients with chronic heart failure. However, the relationship between direct bilirubin and prognosis in patients with HFpEF is unclear.

详细描述

Patients with heart failure with preserved ejection fraction account for approximately 50% of all heart failure patients, have approximately 1.4 hospitalisations per year and an annual mortality rate of approximately 15%. Till now, there have no definitively proven therapies that can reduce their morbidity and mortality, HFpEF Patients have a poor prognosis. The current study found that the prognosis of patients with HFpEF may be related to the heterogeneity of the disease, its various phenotypes and multifactorial pathophysiology, which has not been fully elucidated. The current study found that bilirubin is a risk factor for adverse outcomes of various HFpEF-related complications, but the relationship between direct bilirubin and prognosis of HFpEF has not been reported. Therefore the investigators speculate that direct bilirubin is a predictor of prognosis of HFpEF patients.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult aged ≥18 years old;
  • Diagnosed with HFpEF.
  • Diagnostic criteria including:
  • left ventricular ejection fraction ≥ 50%;
  • with the symptoms and/or signs of heart failure;
  • Patients in sinus rhythm:BNP≥35pg/ml and/or NT-proBNP≥125pg/ml;Patients with atrial fibrillation:BNP≥105pg/ml and/or NT-proBNP≥365pg/ml.

排除标准

  • LVEF less than 49% at any time

结局指标

主要结局

The level of direct bilirubin

时间窗: The day when patients on admission

The level of direct bilirubin

a composite of heart failure rehospitalization or all-cause mortality

时间窗: In an average of 3 year after discharge

a composite of heart failure rehospitalization or all-cause mortality

次要结局

  • heart failure rehospitalization(In an average of 3 year after discharge)
  • all-cause mortality(In an average of 3 year after discharge)

研究者

发起方
Chongqing Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Dongying Zhang

Clinical Professor

Chongqing Medical University

研究点 (1)

Loading locations...

相似试验

Effect of Bilirubin on Prognosis in Heart Failure... | 临床试验